Omron (OTCMKTS:OMRNY) Shares Down 7.4% – Should You Sell?

Omron Corp. (OTCMKTS:OMRNY) shares were down 7.4% on Friday. The company traded as low as $36.78 and last traded at $36.78. Approximately 1,132 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 46,236 shares. The stock had previously closed at $39.74.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Omron from a “strong sell” rating to a “hold” rating in a research report on Monday, August 10th. Two investment analysts have rated the stock with a Hold rating. According to MarketBeat, Omron presently has a consensus rating of “Hold”.

Omron Price Performance

The firm has a market cap of $7.54 billion, a P/E ratio of 34.83, a price-to-earnings-growth ratio of 0.78 and a beta of 1.22. The business has a 50-day simple moving average of $40.47 and a 200 day simple moving average of $36.56. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.49 and a current ratio of 1.93.

Institutional Investors Weigh In On Omron

A hedge fund recently raised its position in Omron stock. GAMMA Investing LLC lifted its position in shares of Omron Corp. (OTCMKTS:OMRNY) by 12.1% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,536 shares of the company’s stock after buying an additional 382 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $144,000 at the end of the most recent quarter. 1.09% of the stock is currently owned by hedge funds and other institutional investors.

Omron Company Profile

Omron Corporation is a Japan-based technology company that develops automation, sensing, control and healthcare solutions. Its products include industrial sensors, controllers, machine-vision and inspection systems, safety equipment, robotics and other factory-automation technologies used to improve manufacturing productivity and quality.

Through its healthcare business, Omron provides blood-pressure monitors, electrocardiographs, nebulizers, body-composition monitors and related digital health services for consumers and medical professionals.